These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17412473)

  • 1. Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
    Ruhrmann S; Kissling W; Lesch OM; Schmauss M; Seemann U; Philipp M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1012-22. PubMed ID: 17412473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
    Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
    Yen YC; Lung FW; Chong MY
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
    Pajonk FG
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
    Möller HJ; Pelzer E; Kissling W; Riehl T; Wernicke T
    Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid].
    Pach J; Finkbeiner T; Glaser T; Haug J; Osterheider M; Tegeler J
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10):442-9. PubMed ID: 9825249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flupenthixol versus haloperidol in acute psychotic episodes].
    Parent M; Toussaint C
    Acta Psychiatr Belg; 1982; 82(6):617-31. PubMed ID: 7183131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of risperidone in chronic schizophrenic Thai patients.
    Werapongset W; Chaisirikul S; Chrujiporn W; Visanuyothin T; Kessawai D; Charisilp C; Ratanachata N; Sanichwannakul K; Wangdee P; Bunditchate A; Ukranand P
    J Med Assoc Thai; 1998 May; 81(5):324-8. PubMed ID: 9623031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 11. Case study: risperidone in children and adolescents with schizophrenia.
    Quintana H; Keshavan M
    J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1292-6. PubMed ID: 7592266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors connected with the effect of risperidone on psychopathological symptoms and working memory in schizophrenia].
    Borkowska A; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):225-33. PubMed ID: 12647443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Profile of the action of neuroleptics in deficit schizophrenia].
    Vanelle JM
    Encephale; 1996 Jun; 22 Spec No 2():33-9. PubMed ID: 8767040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative Efficacy of Flupentixol and Risperidone on Schizophrenic Negative Symptoms].
    Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
    Psychiatr Prax; 2003 May; 30(Suppl 2):94-96. PubMed ID: 13130348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patients.
    Hertling I; Philipp M; Dvorak A; Glaser T; Mast O; Beneke M; Ramskogler K; Saletu-Zyhlarz G; Walter H; Lesch OM
    Neuropsychobiology; 2003; 47(1):37-46. PubMed ID: 12606844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of risperidone on cognitive functions in schizophrenia.
    Barkić J; Filaković P; Radanović-Grgurić L; Koić O; Laufer D; Pozgain I; Koić E; Hotujac L
    Coll Antropol; 2003; 27 Suppl 1():111-8. PubMed ID: 12955900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia.
    Lindström E; Eriksson B; Hellgren A; von Knorring L; Eberhard G
    Clin Ther; 1995; 17(3):402-12. PubMed ID: 7585844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
    Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
    Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Remission of schizophrenic psychosis with negative symptoms with risperidone].
    Lübbe R
    Fortschr Med; 1996 Feb; 114(6):35-6. PubMed ID: 8900527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.